ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "U.S. Healthcare Reimbursement Guidance for Foreign Life Sciences Companies"
Episode Synopsis
In this episode, Mike Burke, AGG Corporate partner and co-chair of the firm’s International practice, is joined by Andrew Tsui, AGG Healthcare Litigation partner, to explore the intricacies of reimbursement in the U.S. healthcare system. Mike and Andrew discuss challenges foreign life sciences companies face related to Medicare and Medicaid reimbursement, the regulatory hurdles involved, and common pitfalls to avoid. They also highlight the importance of understanding compliance requirements, enforcement mechanisms, and the role of federal agencies in shaping payment determinations.
More episodes of the podcast AGG Talks: Cross-Border Business
Understanding Sweden’s Foreign Direct Investment Act and Its Impact on Cross-Border Transactions
16/10/2025
How Life Sciences Companies Can Create a Culture of Compliance When Expanding to the U.S. Market
30/04/2025
U.S. Enforcement Trends Targeting Foreign Pharmaceutical and Medical Device Manufacturers
06/03/2025
In God we trust